← Mechanisms of action
EPCAM
SINGLE PROTEINHomo sapiens
Preferred name: Epithelial cell adhesion molecule ChEMBL ↗
Linked proteins
Drugs acting on this target (36)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| 323/A3 | Adcc | experimental | mAb | EpCAM |
| CO17-1A | Adcc | experimental | mAb | EpCAM |
| A-337 | Antagonist | experimental | mAb | EpCAM |
| [123i]i-darpin-ec1 | Binding agent | experimental | Small molecule | EPCAM binding agent |
| ba3182 | Binding agent | experimental | mAb | EPCAM binding agent |
| BIS-1 | Binding agent | experimental | mAb | EPCAM binding agent |
| catumaxomab (Removab) | Binding agent | experimental | mAb | EPCAM binding agent |
| cx-2051 | Binding agent | experimental | mAb | EPCAM binding agent |
| edrecolomab | Binding agent | experimental | mAb | EPCAM binding agent |
| ign-101 | Binding agent | experimental | Biological | EPCAM binding agent |
| KS1/4 | Binding agent | experimental | mAb | EpCAM |
| moc31-pe | Binding agent | experimental | mAb | EPCAM binding agent |
| proxinium | Binding agent | experimental | mAb | EPCAM binding agent |
| vb4-845 | Binding agent | experimental | mAb | EpCAM |
| vb6-845 | Binding agent | experimental | Recombinant protein | EPCAM binding agent |
| catumaxomab (Removab) | Cross-linking agent | experimental | mAb | EPCAM cross-linking agent |
| edrecolomab | Cross-linking agent | experimental | mAb | EPCAM cross-linking agent |
| adecatumumab | Immunity, passive | experimental | mAb | EPCAM immunity, passive |
| epcam car-t cells | Immunity, passive | experimental | Cell therapy | EPCAM immunity, passive |
| TC99M nofetumomab merpentan (Verluma) | Immunity, passive | approved | mAb | EPCAM immunity, passive |
| adecatumumab | Inhibitor | experimental | mAb | EPCAM inhibitor |
| am-928 | Inhibitor | experimental | mAb | EPCAM inhibitor |
| bnt317 | Inhibitor | experimental | mAb | EPCAM inhibitor |
| edrecolomab | Inhibitor | experimental | mAb | EPCAM inhibitor |
| ing-1 | Inhibitor | experimental | mAb | EPCAM inhibitor |
| kk2269 | Inhibitor | experimental | mAb | EPCAM inhibitor |
| m701 | Inhibitor | experimental | mAb | EPCAM inhibitor |
| moc31-pe | Inhibitor | experimental | mAb | EPCAM inhibitor |
| mt110 | Inhibitor | experimental | mAb | EPCAM inhibitor |
| proxinium | Inhibitor | experimental | mAb | EPCAM inhibitor |
| tucotuzumab celmoleukin | Inhibitor | experimental | mAb | EPCAM inhibitor |
| vb6-845 | Inhibitor | experimental | Recombinant protein | EPCAM inhibitor |
| ing-1 | Other | experimental | mAb | EPCAM other |
| tucotuzumab celmoleukin | Other | experimental | mAb | EPCAM other |
| [18f]f-resca-epcd6 | Radiopharmaceutical | experimental | Small molecule | EPCAM radiopharmaceutical |
| [68ga]ga-nota-epcd6 | Radiopharmaceutical | experimental | Peptide | EPCAM radiopharmaceutical |